BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1566414)

  • 1. Role of splenectomy as adjunctive therapy in suppressing cardiac xenograft humoral immunity.
    Carobbi A; Araneda D; Marchman W; Patselas T; Thomas F; Thomas J
    Transplant Proc; 1992 Apr; 24(2):521-2. PubMed ID: 1566414
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
    Quarantillo P; Araneda D; Thomas F; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation.
    Hayashi S; Ito M; Yokoyama I; Uchida K; Takagi H
    Transplant Proc; 1994 Jun; 26(3):1284. PubMed ID: 7518126
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival.
    Carobbi A; Araneda D; Patselas T; Thomas J; Mosca F; Thomas F
    Transplant Proc; 1991 Feb; 23(1 Pt 1):549-50. PubMed ID: 1703704
    [No Abstract]   [Full Text] [Related]  

  • 6. Induced tolerance and flow cytometry analysis of lymphocyte phenotypes in concordant xenograft transplantation.
    Jensen JE; Jensen PB; Nielsen B; Koch C; Larsen S; Horn T; Kemp E
    Transplant Proc; 1996 Apr; 28(2):721-3. PubMed ID: 8623364
    [No Abstract]   [Full Text] [Related]  

  • 7. Recipient pretreatment permits long-term xenograft survival on a relatively low dose cyclosporine maintenance therapy.
    Bouwman E; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1992 Apr; 24(2):519-20. PubMed ID: 1566413
    [No Abstract]   [Full Text] [Related]  

  • 8. Splenectomy is a potent immunosuppressive modality for cardiac xenografting.
    Carobbi A; Araneda D; Thomas F; Quarantillo P; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):419-20. PubMed ID: 8438360
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survival of disparate cardiac xenografts: induction of tolerance and humoral accommodation.
    Thomas F; Araneda D; Quarantillo P
    Transplant Proc; 1994 Jun; 26(3):1220-3. PubMed ID: 8029894
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract]   [Full Text] [Related]  

  • 11. Examination of the clonal deletion theory in the guinea pig to Lewis rat cardiac xenograft model.
    Boyle EM; Fischel RJ; Johnson EM; Leventhal J; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):632. PubMed ID: 1566458
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of leflunomide, cyclosporine, and splenectomy in two different organ systems of concordant xenotransplantation in rats.
    Salomon S; Steinbrüchel DA; Nielsen B; Lillevang S; Kemp E
    Transplant Proc; 1996 Apr; 28(2):698-9. PubMed ID: 8623352
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4 MAb therapy diminishes sensitization to xenoantigen and abrogates hyperacute rejection of hamster cardiac grafts in rats.
    Sablinski T; Hancock WW; Schmidbauer G; Milford EL; Kupiec-Weglinski JW
    Transplant Proc; 1992 Apr; 24(2):528-30. PubMed ID: 1566417
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic and xenogeneic cross-reactions in hyperimmune recipients.
    Di Stefano R; Carobbi A; Frosini F; Scavuzzo M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):446. PubMed ID: 8438372
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of xenograft survival by exchange transfusions and immunosuppression.
    Bouwman E; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1990 Jun; 22(3):1079-80. PubMed ID: 2190374
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of splenectomy on cardiac and liver xenografts in the nude rat.
    Tsugita M; Valdivia LA; Woo J; Demetris AJ; Celli S; Pan F; Frye C; Fung JJ
    Transplant Proc; 1994 Jun; 26(3):1210. PubMed ID: 8029890
    [No Abstract]   [Full Text] [Related]  

  • 17. Xenograft tolerance induced by intrathymic spleen cell injection.
    Sheffield CD; Hadley GH; Bartlett ST
    Transplant Proc; 1994 Jun; 26(3):1204. PubMed ID: 8029887
    [No Abstract]   [Full Text] [Related]  

  • 18. Timing of splenectomy is critical in prolongation of cardiac xenografts.
    Araneda D; Carobbi A; Patselas T; Thomas F; Thomas J
    Transplant Proc; 1992 Apr; 24(2):523-4. PubMed ID: 1566415
    [No Abstract]   [Full Text] [Related]  

  • 19. Pretransplant donor antigen and cyclophosphamide in the evaluation of the clonal deletion theory in the hamster to Lewis rat cardiac xenograft model.
    Boyle EM; Fischel RJ; Johnson EM; Leventhal J; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):698. PubMed ID: 1566486
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolongation of hamster-to-rat cardiac xenograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Hung CJ; Arakawa K; Oka T
    Transplant Proc; 1996 Jun; 28(3):1397-9. PubMed ID: 8658711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.